STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
80 hedge funds and large institutions have $236M invested in Stemline Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 79 → 80 (+1)
Holders
80
Holding in Top 10
1
Calls
$2.07M
Puts
$1.41M
Top Buyers
| 1 | +$35.1M | |
| 2 | +$12.1M | |
| 3 | +$4.84M | |
| 4 |
LSC
Lyon Street Capital
Sausalito,
California
|
+$4.49M |
| 5 |
Millennium Management
New York
|
+$4M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$3.16M | |
| 3 | -$2.85M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.24M |
| 5 |
Axa
Paris,
France
|
-$1.1M |